The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...
Dr Dana Rizk discusses Voyxact (sibeprenlimab-szsi), a new FDA-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results